Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Gymboree attributes the rise to better than anticipated gross margin rates resulting from better management of inventory and markdowns. Same store sales are still expected to be in the range of the low to mid-single digits.
Gymboree is a specialty children's retailer of clothing and accessories with 956 stores in the United States, Canada and Puerto Rico.
Gymboree's Earnings Surprise Streak
The company continues to beat estimates as it has now racked up a 7 quarter earnings surprise winning streak. Over the last 4 quarters, Gymboree has surprised on average of 3.98%. It is expected to report fiscal fourth quarter results on Mar 10.
You can see its solid earnings surprise track record below:
Value Fundamentals
Gymboree still has attractive valuations. It is trading with a forward P/E of 12.4 and a price-to-book ratio of 2.86. Gymboree also has an outstanding 1-year return on equity of 26.2%, way above the industry average of 7.98%.
Read the Oct 5, 2009 article.
Update to Previous Value Zacks Rank Buy Stocks
E-House China Holdings (EJ) is cashing in on China's super hot housing market as fourth quarter revenue is expected to jump more than 160%. The stock has attractive valuations. E-House is trading at just 11.6x forward earnings. Read the full article.
Gafisa SA (GFA) is cashing in on Brazil's growing need for housing as sales climbed in the third quarter. GFA has attractive valuations. It is trading at just 11.3x forward earnings. Read the full article.
The Hartford Financial Services (HIG) recently sharply raised guidance for the fourth quarter. The company trades with a PEG ratio of just 0.64. Read the full article.
Cymer, Inc. (CYMI) has seen demand pick up for its light sources as the semiconductor industry ramps up production. CYMI has surprised on estimates 2 out of the last 4 quarters by an average of 45.64%. Cymer is trading at 14.8x forward earnings. Read the full article.
Tracey Ryniec is the Value Stock Strategist for Zacks.com. She is also the Editor in charge of the market-beating Zacks Value Trader service.